Your browser doesn't support javascript.
loading
A multicentre cluster-randomized clinical trial to improve antibiotic use and reduce length of stay in hospitals: comparison of three measurement and feedback methods.
Kallen, M C; Hulscher, M E J L; Elzer, B; Geerlings, S E; van der Linden, P D; Teerenstra, S; Natsch, S; Opmeer, B C; Prins, J M.
Afiliación
  • Kallen MC; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Meibergdreef 9, Amsterdam, The Netherlands.
  • Hulscher MEJL; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Geert Grooteplein Zuid 10, Nijmegen, The Netherlands.
  • Elzer B; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Meibergdreef 9, Amsterdam, The Netherlands.
  • Geerlings SE; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Meibergdreef 9, Amsterdam, The Netherlands.
  • van der Linden PD; Tergooi Hospital, Department of Clinical Pharmacy, Van Riebeeckweg 212, Hilversum, The Netherlands.
  • Teerenstra S; Radboud University Medical Center, Radboud Institute for Health Sciences, Department for Health Evidence, Group Biostatistics, Geert Grooteplein Zuid 10, Nijmegen, The Netherlands.
  • Natsch S; Radboud University Medical Center, Department of Pharmacy, Geert Grooteplein Zuid 10, Nijmegen, The Netherlands.
  • Opmeer BC; Amsterdam UMC, University of Amsterdam, Clinical Research Unit, Meibergdreef 9, Amsterdam, The Netherlands.
  • Prins JM; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Meibergdreef 9, Amsterdam, The Netherlands.
J Antimicrob Chemother ; 76(6): 1625-1632, 2021 05 12.
Article en En | MEDLINE | ID: mdl-33638644
ABSTRACT

BACKGROUND:

Various metrics of hospital antibiotic use might assist in guiding antimicrobial stewardship (AMS).

OBJECTIVES:

To compare patient outcomes in association with three methods to measure and feedback information on hospital antibiotic use when used in developing an AMS intervention.

METHODS:

Three methods were randomly allocated to 42 clusters from 21 Dutch hospitals (1) feedback on quantity of antibiotic use [DDD, days-of-therapy (DOT) from hospital pharmacy data], versus feedback on (2) validated, or (3) non-validated quality indicators from point prevalence studies. Using this feedback together with an implementation tool, stewardship teams systematically developed and performed improvement strategies. The hospital length of stay (LOS) was the primary outcome and secondary outcomes included DOT, ICU stay and hospital mortality. Data were collected before (February-May 2015) and after (February-May 2017) the intervention period.

RESULTS:

The geometric mean hospital LOS decreased from 9.5 days (95% CI 8.9-10.1, 4245 patients) at baseline to 9.0 days (95% CI 8.5-9.6, 4195 patients) after intervention (P < 0.001). No differences in effect on LOS or secondary outcomes were found between methods. Feedback on quality of antibiotic use was used more often to identify improvement targets and was preferred over feedback on quantity of use. Consistent use of the implementation tool seemed to increase effectiveness of the AMS intervention.

CONCLUSIONS:

The decrease in LOS versus baseline likely reflects improvement in the quality of antibiotic use with the stewardship intervention. While the outcomes with the three methods were otherwise similar, stewardship teams preferred data on the quality over the quantity of antibiotic use.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Programas de Optimización del Uso de los Antimicrobianos / Antibacterianos Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Programas de Optimización del Uso de los Antimicrobianos / Antibacterianos Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos